News, Resources, and Events

June 3, 2009:  Clario Medical Imaging and Imaging Biometrics announce integration of zVision^TM and IB Neuro^TM  Read More... 

January 2009:   One thing in Jim's favor was the recurrence was caught early... Credit goes to...  Extending Life, Sustaining LIves    Read More... 

June 11, 2008:  ACRIN Enters Agreement with Imaging Biometrics    Read More...

May 31, 2008:  FDA Clears imaging Biomerics MR Perfusion Software, IB Neuro^TM   Read More...

• Determination of rCBV in brain tumors is most accurate when using either a preload/post-processing correction method or a dual-echo acquisition approach  g/cgi/content/abstract/2492071659. 

  Paulson ES, Schmainda KM,  Radiology 2008, 10.1148/radiol.2492071659) 
• Tumor rCBV shows a significant correlation with tumor grade.  Schmainda KM, et al., Am J Neuroradiology 24:1524-1532 (2004)
• The importance of leakage correction is demonstrated and defined.   Boxerman JL, et al., Am J Neuroradiology 27:859-67 (2006)
• The role of rCBV mapping to evaluate anti-angiogenic therapies is demonstrated in a rate brain tumor model.   Quarles CC, Schmainda KM. Magnetic Resonance in Medicine 57(4):680-687 (2007)
• The role of rCBV imaging to evaluate the response of brain tumors to anti-angiogenic therapies is demonstrated in patients.   Batchelor T, et al,. Cancer Cell 11(1): 83-95 (2007)